Pfizer’s RSV Vaccine Shows Efficacy In Older Adults, Setting Up Showdown With GSK

 
• By Joseph Haas
  
RSV illustration
Pfizer is readying a BLA filing for its RSV vaccine candidate • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D